# U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 25% Upside Potential

- Link: https://www.directorstalkinterviews.com/u-s-physical-therapy-inc-usph-stock-analysis-exploring-a-25-upside-potential/4121233673
- Published: 2026-01-06T11:36:50+00:00
- Author: Madison Wilson

U.S. Physical Therapy, Inc. (NYSE: USPH) is a prominent player in the healthcare
sector, specifically within the medical care facilities industry. With a market 
capitalization of $1.28 billion, the company has carved out a significant niche 
in the U.S. healthcare landscape by managing outpatient physical therapy clinics
and providing industrial injury prevention services. Based in Houston, Texas, USPH
has been operational since 1990 and offers an array of services ranging from post-
operative care to ergonomic assessments for Fortune 500 companies.

For individual investors, USPH presents an intriguing opportunity, not least due
to the stock’s current trading price of $84.24, which sits comfortably within its
52-week range of $65.08 to $93.16. This is bolstered by a potential upside of 25.04%
based on an average target price of $105.33, as suggested by analysts. The stock’s
resilience and growth prospects are further underscored by a revenue growth rate
of 17.30%, signaling robust demand for its services.

In terms of valuation, USPH’s forward P/E ratio stands at 28.13, indicating that
investors are willing to pay a premium for future earnings growth. This optimism
is supported by the company’s earnings per share (EPS) of 2.37 and a return on equity
of 8.44%, which reflect its ability to generate profits from shareholders’ equity.
Additionally, USPH boasts a free cash flow of approximately $34.74 million, providing
it with ample liquidity to reinvest in operations or distribute dividends to shareholders.

Speaking of dividends, USPH offers a yield of 2.14%, with a payout ratio of 75.53%.
While this suggests a significant portion of earnings is returned to shareholders,
it also reflects the company’s commitment to providing steady income streams for
its investors.

Analyst ratings paint a positive picture, with six buy ratings and only one hold,
and no sell recommendations. This consensus underscores favorable sentiment in the
market, further supported by a target price range of $98.00 to $113.00, indicating
confidence in the company’s growth trajectory.

From a technical perspective, USPH’s stock price is trading above both its 50-day
and 200-day moving averages, which are $78.58 and $78.19 respectively. This bullish
trend is complemented by a Relative Strength Index (RSI) of 56.72, suggesting the
stock is neither overbought nor oversold. The Moving Average Convergence Divergence(
MACD) of 1.06, with a signal line of 0.74, indicates a positive momentum that could
attract momentum-focused investors.

Investors considering USPH should be aware of its dual-segment operational model,
which not only diversifies its revenue streams but also mitigates sector-specific
risks. The physical therapy operations cater to a wide array of therapeutic needs,
while the industrial injury prevention services provide tailored solutions to large
corporate clients, thereby expanding its market reach.

As USPH continues to expand its footprint in both outpatient physical therapy and
industrial injury prevention, it stands as a compelling investment option for those
seeking exposure to the healthcare sector. The combination of strong revenue growth,
attractive dividend yield, and positive analyst ratings makes U.S. Physical Therapy,
Inc. a stock worth watching for potential long-term gains.

Share on:
